(Q44346396)

2 December 2017

title

Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors (English)

1 reference

2 December 2017

1 reference

Mayumi Saito

1

1 reference

2 December 2017

Toshihiko Ishimitsu

2

1 reference

2 December 2017

Junichi Minami

3

1 reference

2 December 2017

Hidehiko Ono

4

1 reference

2 December 2017

Masami Ohrui

5

1 reference

2 December 2017

Hiroaki Matsuoka

6

1 reference

2 December 2017

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

167

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

73-79

1 reference

Atherosclerosis — An Inflammatory Disease

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

The primary prevention of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Essential hypertension, metabolic disorders, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Effect of alcohol consumption on systemic markers of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Cytokines in alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Elevated C-reactive protein levels in overweight and obese adults

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

inferred from DOI database lookup

7 January 2021

based on heuristic

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Direct proinflammatory effect of C-reactive protein on human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

The pathophysiologic roles of interleukin-6 in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Elevated Levels of Interleukin-6 in Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Circadian characteristics of circulating interleukin-6 in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Vitamin E and heart disease: basic science to clinical intervention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Current perspectives on statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Clinical outcomes in statin treatment trials: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Weight loss reduces C-reactive protein levels in obese postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900380-5

10.1016/S0021-9150(02)00380-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference